Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome

被引:18
|
作者
Rhee, Chin Kook [1 ]
机构
[1] Catholic Univ Korea, Div Pulm & Crit Care Med, Dept Internal Med, Seoul St Marys Hosp,Coll Med, Seoul 137701, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2015年 / 30卷 / 04期
关键词
Asthma; Pulmonary disease; chronic obstructive; Phenotype; PLACEBO-CONTROLLED TRIAL; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; TIOTROPIUM BROMIDE; CHILDHOOD ASTHMA; DOUBLE-BLIND; COPD-ASTHMA; EXACERBATIONS; AZITHROMYCIN; SMOKERS;
D O I
10.3904/kjim.2015.30.4.443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many patients with asthma or chronic obstructive pulmonary disease (COPD) have overlapping characteristics of both diseases. By spirometric definition, patients with both fixed airflow obstruction (AO) and bronchodilator reversibility or fixed AO and bronchial hyperresponsiveness can be considered to have asthma-COPD overlap syndrome (ACOS). However, patients regarded to have ACOS by spirometric criteria alone are heterogeneous and can be classified by phenotype. Eosinophilic inflammation, a history of allergic disease, and smoke exposure are important components in the classification of ACOS. Each phenotype has a different underlying pathophysiology, set of characteristics, and prognosis. Medical treatment for ACOS should be tailored according to phenotype. A narrower definition of ACOS that includes both spirometric and clinical criteria is needed.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 50 条
  • [21] The Physiology of Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Kaminsky, David A.
    Irvin, Charles G.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 575 - 589
  • [22] Pathophysiology of Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Hudler, Andi
    Holguin, Fernando
    Sharma, Sunita
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 521 - 532
  • [23] Epidemiology of Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Fuhlbrigge, Anne L.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 533 - 547
  • [24] Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome
    Harada, Tomoya
    Yamasaki, Akira
    Fukushima, Takehito
    Hashimoto, Kiyoshi
    Takata, Miki
    Kodani, Masahiro
    Okazaki, Ryota
    Takeda, Kenichi
    Watanabe, Masanari
    Kurai, Jun
    Shimizu, Eiji
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 595 - 602
  • [25] The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS)
    Albertson, Timothy E.
    Chenoweth, James A.
    Pearson, Skyler J.
    Murin, Susan
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (02) : 213 - 231
  • [26] Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism
    Yeh, Jun-Jun
    Wang, Yu-Chiao
    Kao, Chia-Hung
    PLOS ONE, 2016, 11 (09):
  • [27] Reply to: Asthma-chronic obstructive pulmonary disease overlap syndrome: Is prediction feasible?
    Ayub, Irfan Ismail
    Arshad, Abdul Majeed
    Sekar, Prathipa
    Manimaran, Natraj
    Thangaswamy, Dhanasekar
    Chockalingam, Chandrasekar
    LUNG INDIA, 2018, 35 (06) : 541 - 543
  • [28] Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis
    Rodrigue, Claudie
    Beauchesne, Marie-France
    Mallette, Valerie
    Lemiere, Catherine
    Larivee, Pierre
    Blais, Lucie
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 14 (03) : 330 - 338
  • [29] Asthma-chronic obstructive pulmonary disease overlap syndrome: A diagnostic puzzle for the clinicians
    Ourania Koltsida
    Antonia Koutsoukou
    Nikolaos G Koulouris
    Nikoletta Rovina
    World Journal of Respirology, 2016, (02) : 54 - 56
  • [30] Effects of Dupilumab for Asthma-chronic Obstructive Pulmonary Disease Overlap
    Kodaka, Norio
    Nakano, Chihiro
    Oshio, Takeshi
    Hirouchi, Takatomo
    Yamada, Yuka
    Matsuse, Hiroto
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2023, 22 (02) : 212 - 216